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Abstract. 
 
Here, we describe the isolation of adenine 
nucleotide translocase-1 (ANT-1) in a screen for domi-
nant, apoptosis-inducing genes. ANT-1 is a component 
of the mitochondrial permeability transition complex, a 
protein aggregate connecting the inner with the outer 
mitochondrial membrane that has recently been impli-
cated in apoptosis. ANT-1 expression led to all features 
of apoptosis, such as phenotypic alterations, collapse of 
the mitochondrial membrane potential, cytochrome c 
release, caspase activation, and DNA degradation. 
Both point mutations that impair ANT-1 in its known 
 
activity to transport ADP and ATP as well as the NH
 
2
 
-
terminal half of the protein could still induce apoptosis. 
Interestingly, ANT-2, a highly homologous protein 
could not lead to cell death, demonstrating the speciﬁc-
ity of the signal for apoptosis induction. In contrast to 
Bax, a proapoptotic Bcl-2 gene, ANT-1 was unable to 
elicit a form of cell death in yeast. This and the ob-
served repression of apoptosis by the ANT-1–interact-
ing protein cyclophilin D suggest that the suicidal effect 
of ANT-1 is mediated by speciﬁc protein–protein inter-
actions within the permeability transition pore.
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A
 
POPTOSIS
 
 is a form of cell death that plays a role in de-
 
velopment, tissue homeostasis, and disease (White,
1996). Its induction must be tightly regulated. Oth-
erwise, serious consequences may follow. A hyperactive
apoptosis induction might lead to degenerative diseases
like Alzheimer’s disease (Loo et al., 1993); a reduced ac-
tivity can contribute to the multistep process of tumori-
genesis since tumor cells are exposed to multiple proapop-
totic stimuli (McGill, 1997). Therefore, the induction of
apoptosis is governed by an elaborate array of checks and
balances in the cell. Eventually, a family of cysteine pro-
teases, the so-called caspases, is activated (Salvesen and
Dixit, 1997). These enzymes can cleave specific substrates
in the cell that leads to the typical apoptotic phenotype
and the self-destruction of the cell.
The first indication that mitochondria play a role in
apoptosis induction was the observation that an in vitro
system for apoptosis induction required the presence of
mitochondria (Newmeyer et al., 1994). The permeability
transition pore (PT pore)
 
1
 
 complex (Zoratti and Szabo,
1995), a protein aggregate that resides in contact sites of
the inner and outer mitochondrial membrane, was subse-
quently identified as being responsible for apoptosis in-
duction (Petit et al., 1995; Zamzami et al., 1995b). Multiple
pharmacological stimuli have been shown to activate this
complex by as yet unknown means (Petit et al., 1995;
Fulda et al., 1998; Zamzami et al., 1998). The activated
complex leads to the collapse of the potential over the in-
ner mitochondrial membrane (
 
DC
 
m
 
), swelling of mito-
chondria, and the generation of oxygen radicals (Zamzami
et al., 1995a; Vander Heiden et al., 1997). The subsequent
release of apoptogenic caspases (Susin et al., 1999a) and a
putative oxidoreductase (Susin et al., 1999b) aids in apop-
tosis induction.
Many genes involved in apoptosis have the dominant ca-
pacity to induce cell death upon overexpression. This fea-
ture is even conserved across species (McCarthy and Dixit,
1998). It might be explained by the fact that the overex-
pressed proteins engage in protein–protein contacts and
can thereby create the signal for apoptosis (Yang et al.,
1998). Consequently, we have recently developed a screen
for dominant, apoptosis-inducing genes (Grimm and Le-
der, 1997). The screen is based on the iterative transfec-
tion of small plasmid pools of a normalized cDNA library
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into mammalian cells and the morphological determina-
tion of apoptosis induction. Here, we describe the charac-
terization of adenine nucleotide translocase-1 (ANT-1), a
central component of the permeability transition pore,
which was identified using such a screen.
ANT-1 has recently been shown to be required for apop-
tosis mediated by Bax, another component of the PT com-
plex (Marzo et al., 1998a). Conversely, ANT-1 can induce
apoptosis in a Bax-dependent manner. For this, ANT-1
must be inactivated pharmacologically by the plant gluco-
side atractyloside, which arrests ANT-1 in a specific con-
formation and causes PT pore opening (Zoratti et al.,
1982; Davidson and Halestrap, 1987). However, in our ex-
periments with ANT-1, such a secondary signal is not re-
quired for apoptosis induction. ANT-1’s apoptosis activity
does not seem to depend on its known function for ADP/
ATP exchange because several transport inactive mutants
could still lead to cell death. Surprisingly, we found that a
very homologous protein, the ANT-2 transporter, was in-
active for apoptosis induction. Furthermore, ANT-1 could
not elicit a form of cell death in yeast. This is in contrast to
Bax that directly interacts with ANT-1 and can domi-
nantly induce cell death in yeast. This result suggests that
ANT-1–mediated apoptosis induction depends on pro-
tein–protein interactions that are specific for mammalian
cells. Since ANT-1 is activated by overexpression for
apoptosis induction, it is interesting to note that this gene
is already highly expressed in mitochondria. This suggests
that in a normal cell it must be kept inactive by other pro-
teins of the PT pore, which implies important stoichio-
metric correlations between the various components of
this complex. Consistent with this, we found that cyclophi-
lin D, another component of the PT pore, can repress
ANT-1–induced apoptosis. Furthermore, our data could
help to explain the observed apoptosis induction in dilated
cardiomyopathy (DCM), a degenerative disease of the
heart muscle that is marked by a dramatic increase of the
expression level of ANT-1 and by excessive apoptosis in-
duction. These findings are, up to now, the most direct ge-
netic evidence that the PT pore can signal apoptosis, and
may lead to the molecular elucidation of how this complex
can be activated for apoptosis induction.
 
Materials and Methods
 
Plasmids
 
The hemagglutinin (HA) tag vector (pHA) for the expression of HA fu-
sion proteins was constructed by annealing oligos coding for the HA
epitope (YPYDVPDYA) and inserting them between the NotI and XbaI
site into the pcDNA3 vector (Invitrogen Corp.). The correct sequence was
verified by sequencing. The point mutants of ANT-1 were engineered by
recombinant PCR using suitable primers. All amino acid changes were
verified by sequencing. Deletion mutagenesis of ANT-1 was achieved
with PCR using the same enzyme. For all the PCR reactions, Pwo, a ther-
mostable polymerase with proofreading function (Roche Diagnostics) was
employed with 22 cycles and 200 ng of template. All deletion and point
mutants of ANT-1 contained the same Kozak sequence and were inserted
into the HA tag vector (pHA) with BamHI and NotI. ANT-2 was ampli-
fied from a mouse kidney cDNA library and cyclophilin D from a 293T li-
brary, both by using specific primers. The correct sequence was verified by
sequencing. The eukaryotic expression vector for baculovirus p35 has
been described (Clem and Miller, 1994). Reverse transcriptase–PCR was
used to clone the mouse ANT-2 (5
 
9
 
 primer, 5
 
9
 
-TCAGGATCCTTTCAA-
CATGACAGATGC-3
 
9
 
; and 3
 
9
 
 primer, 5
 
9
 
-TAGTGCATGCGGCCGC-
 
CTGTGTATTTCTTGATCTCATC-3
 
9
 
) and the human cyclophilin D
(5
 
9
 
 primer, 5
 
9
 
-ATCGGATCCATTAGCCATGGTCAACCC-3
 
9
 
; and 3
 
9
 
primer, 5
 
9
 
-TAGTCGGTGCGGCCGCCTTCGAGTTGTCCACAGTC-3
 
9
 
).
Both were inserted into the pHA vector.
 
Cell Cultivation and Transfection
 
Human embryonic kidney cells (293T) (Graham et al., 1977; Pear et al.,
1993) and BHK cells were kept in DME medium supplemented with 5%
FCS (Sigma Chemical Co.); all other cell lines were cultivated in DME
and 10% FCS with the exception of PC3 cells, which were held in RPMI
with 10% FCS. All transfections were done by calcium phosphate copre-
cipitation as described (Roussel et al., 1984), except for PC3 cells which
were transfected with Dosper (Roche Diagnostics) and 3T3 cells by using
SuperFect (Qiagen). When the green fluorescent protein (GFP) was
cotransfected, the indicated amount of pLantern vector (GIBCO BRL)
was added to the transfection mix.
 
Isolation of Apoptosis-inducing Genes
 
mRNA was isolated from 10-wk-old CD1 mice and normalized as de-
scribed (Grimm and Leder, 1997). The cDNA was inserted into a modi-
fied pcDNA3 vector in which the neomycin resistance gene had been de-
leted (Grimm and Leder, 1997). The screen for dominant apoptosis
inducers was performed essentially as described (Grimm and Leder,
1997). A novel 96-well DNA isolation method allowed a considerably
higher throughput. Human 293T cells were used as a read-out cell line
since this would allow the isolation of genes whose signals are conserved
across species. Apoptosis induction was verified by transfecting the iso-
lated, untagged ANT-1 into mouse L929 and 3T3 cells, the hamster BHK
cell line, and human HeLa, MCF-7, and PC3 cells.
 
Immunoblotting
 
For detecting cytochrome c, 293T cells were transfected with an expres-
sion vector for ANT-1. After 18 h, the cells were harvested and the cyto-
plasmic extracts were prepared as described (Ferrari et al., 1998). Protein
samples of 30 
 
m
 
g were loaded on SDS–polyacrylamide gels (10%), and
then electrophoretically transferred onto polyvinylidene fluoride (PVDF)
membranes (Amersham). Western blots were probed with a monoclonal
cytochrome c antibody (PharMingen) and anti-mouse HRP-conjugated
antibody before enhanced chemiluminescence (ECL)–based detection
(Amersham). For the poly-ADP-ribose polymerase (PARP) Western
blot, nuclear fractions were obtained by differential centrifugation as de-
scribed previously (Schreiber et al., 1989). Aliquots of 50 
 
m
 
g protein were
subjected to SDS-PAGE (8% polyacrylamide) and blotted onto PVDF
membranes. PARP and cleavage products were detected using a poly-
clonal serum directed against full-length PARP (Roche Diagnostics), anti-
rabbit HRP-conjugated antibody (Amersham) and the ECL system. For
the detection of HA-tagged ANT isoforms, mitochondria were isolated by
differential centrifugation as described previously (Gawaz et al., 1990). 35-
 
m
 
g protein samples were separated on 10% polyacrylamide gels and blot-
ted onto PVDF membranes. Detection was performed using a rat mAb
raised against the influenza virus HA peptide (Roche Diagnostics) and
the ECL system (Amersham).
 
Yeast Methods
 
Standard yeast methods were applied (Ausubel et al., 1991). For the in-
ducible expression of Bax and ANT-1, the cDNAs were subcloned into
pYESTrp2 (Invitrogen Corp.) in which the B42 fusion moiety was re-
moved.
For induction of the expression constructs, EGY 48 yeast cells (
 
MAT
 
a
 
trp1 ura3 his3 leu2::plexAop
 
6
 
-leu2
 
) were grown for 8 h in YC medium with
20% galactose and 20% raffinose instead of glucose. The yeast cells were
harvested and protoplasts were formed by enzymatic digestion of the cell
wall as described (Gawaz et al., 1990). The protein extracts were isolated
as described above. Protein samples were separated on 10% polyacryl-
amide gels and transferred onto PVDF membranes. Western blots were
probed with a polyclonal Bax antibody (Santa Cruz Biotechnology) or
ANT-1 polyclonal serum (provided by M. Klingenberg, Munich, Ger-
many) and anti-rabbit HRP-conjugated antibody before ECL-based de-
tection (Amersham). The anti–Bax antibody recognizes a conserved se-
quence between mouse and human; the anti–ANT-1 serum detects yeast
ANT-1 and also cross-reacts with the mammalian protein. A mouse mAb 
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(Research Diagnostics) was used to detect the cytochrome oxidase sub-
unit I.
 
Apoptosis Detection
 
Low molecular weight DNA from apoptotic cells was isolated and de-
tected as described (Grimm and Leder, 1997). Apoptosis induction was
measured by an ELISA (Roche Diagnostics) specific for nucleosomal
DNA fragments that are released during apoptosis. The recommendations
of the manufacturer were followed. Equal transfection efficiencies were
monitored by cotransfecting an expression plasmid for GFP. Other apop-
tosis quantifications were performed by flow cytometry (Bitzer et al.,
1999). A cotransfected GFP expression plasmid was used to assess the
transfection efficiency. The apoptotic population was put in relation to the
percentage of GFP-positive cells. The apoptotic background of the vector
control was subtracted to obtain the specific apoptosis induction. Each
condition was tested in at least three independent experiments.
 
Mitochondrial Membrane Gradient Detection
 
HeLa cells were used for the investigation of the membrane potential of
mitochondria because they display a better integrity of internal structures
after fixation than 293T cells. After transfecting an expression vector for
ANT-1 together with a plasmid for GFP, cells were loaded with Mi-
totracker RedCMXRos (Molecular Probes, Inc.) according to the sugges-
tions of the manufacturer. Images were documented using a Zeiss Ax-
ioplan fluorescence microscope. RedCMXRos fluorescence was exited at
546 nm and emission was imaged at 
 
.
 
590 nm. GFP fluorescence was ex-
ited at 450–490 nm, and emission was monitored at 515–565 nm.
 
Results
 
ANT-1 Induces Cell Death
 
Using our screen for dominant, apoptosis-inducing genes,
we isolated a cDNA whose expression elicited an espe-
cially fast and strong apoptosis response in 293T cells. Se-
quencing revealed that the gene encoded ANT-1, the
ADP/ATP translocator protein of the PT pore (Le Quoc
and Le Quoc, 1988; Halestrap, 1991). ANT was active in a
wide variety of cell types; every cell line tested so far un-
derwent apoptosis after stimulation by ANT-1 (such as
L929, 3T3, HeLa, BHK, MCF-7, and PC3). Fig. 1 shows
the phenotype of control- and ANT-1–transfected HEK
293T cells. Whereas the vector-transfected cells displayed
a normal morphology, ANT-1–expressing cells showed a
constricted cytoplasm and blebbing of the plasma mem-
brane.
To assess the temporal relation between the expression
of ANT-1 and apoptosis induction, we transfected 293T
cells with ANT-1 and investigated apoptosis induction at
different time points. Fig. 2 A shows an increase in cell
death from 5 to over 50% after 20 h. This correlated with
the accumulation of the HA-tagged ANT-1 protein specif-
ically in mitochondrial fractions of the cells (Fig. 2 B). Cy-
tochrome c oxidase was used as a marker protein for the
efficient separation of cytoplasmic and mitochondrial pro-
tein fractions.
Figure 1. ANT-1 expression leads to phenotypic
apoptosis induction. The empty vector or an ex-
pression plasmid for ANT-1 were transiently
transfected into 293T cells. After 16 h, phase-con-
trast pictures were taken at a 200-fold magnifica-
tion.
Figure 2. Time course of apoptosis induction and protein expres-
sion after ANT-1 transfection. (A) Temporal increase of apopto-
sis induced by ANT-1 expression. 1 mg of the HA-tagged ANT-1
plasmid was transfected into 293T cells for each condition. Quan-
titative FACS analysis of sub-G1–positive cells was performed at
the indicated time points. The specific apoptosis induction above
background is shown as a percentage of apoptotic cells relative to
all transfected cells. The means and the SDs are given for each
experiment. (B) Transfected ANT-1 progressively accumulates
in mitochondria. Cytoplasmic and mitochondrial cell fractions
were prepared from aliquots taken from the samples under A. 35
mg of each were subjected to SDS-PAGE and subsequent immu-
noblot analysis using an anti–HA tag antibody to specifically de-
tect the transfected ANT-1. The membrane was stripped and re-
probed with an mAb against subunit I of cytochrome c oxidase
(COX I) to demonstrate the purity of the mitochondrial prepara-
tions. 
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Since ANT-1 is a component of the PT pore whose acti-
vation leads to a dissipation of the proton gradient 
 
DC
 
m
 
over the inner mitochondrial membrane (Le Quoc and Le
Quoc, 1988; Halestrap, 1991), we tested ANT-1–trans-
fected cells for this membrane gradient. To this end, we
cotransfected ANT-1 and an expression vector for GFP
into HeLa cells. The membrane gradient in transfected
and, therefore, GFP-positive cells was assayed with
CMXRos, a dye whose fluorescence is dependent on an
intact membrane potential. Fig. 3 A shows that ANT-1–
expressing cells displayed a reduced mitochondrial fluo-
rescence with this dye. This differential staining is a very
early feature of ANT-1–mediated apoptosis induction
since it could be observed in cells that did not yet display
an altered phenotype.
One of the consequences of mitochondrial damage is
the release of cytochrome c from the inner mitochondrial
membrane space (Kluck et al., 1997; Yang et al., 1997).
Therefore, we assayed the cytoplasm of ANT-1–trans-
fected cells for the presence of cytochrome c. Using a
Western blot, we could detect this protein in the cytoplas-
mic fraction of ANT-1–transfected cells (Fig. 3 B). The re-
leased cytochrome c can bind Apaf-1, a mammalian homo-
logue of the 
 
Caenorhabditis elegans
 
 gene ced-4 that leads
to the aggregation and activation of downstream caspases
(Srinivasula et al., 1998). A substrate for caspases is ICAD
(inhibitor of caspase-activated DNase [CAD]) (Sakahira
et al., 1998). Its degradation leads to the activation of
CAD and the internucleosomal degradation of the DNA,
a well-known biochemical sign of apoptosis. To investigate
the status of the DNA, we transfected 293T cells with a
control vector or ANT-1 and isolated the low molecular
weight DNA. Only ANT-1–transfected cells displayed the
typical DNA ladder (Fig. 4 A). We also investigated the
status of PARP, one of the best known caspase sub-
strates, in ANT-1–transfected cells. A Western blot for
PARP (Fig. 4 B) revealed that ANT-1–transfected cells
degraded PARP and generated the expected protein frag-
ments. Since we have also observed apoptosis induction in
MCF-7 cells (data not shown), a cell line that does not ex-
press caspase-3 (Janicke et al., 1998), we conclude that
ANT-1–induced apoptosis is not dependent on this partic-
ular isoenzyme. According to a recent report (Marzo et al.,
1998a), Bax, a member of the Bcl-2 gene family, interacts
directly with ANT-1 and is also known to induce apoptosis
(Oltvai et al., 1993). However, caspase activation does not
seem to be a necessary event for Bax-induced cell death
(Xiang et al., 1996). Therefore, we wanted to know
whether caspase activation is required for ANT-1 apopto-
sis induction. To address this, we cotransfected ANT-1
and an expression vector for p35, a broad-range caspase
inhibitor from baculovirus (Clem and Miller, 1994). A
quantitative apoptosis assay revealed a sixfold reduction
in apoptosis induction when p35 was cotransfected (Fig. 4
Figure 3. Effect of ANT-1 expression on mitochondria. (A) ANT-1 overexpression leads to the col-
lapse of the inner mitochondrial membrane potential. HeLa cells were transfected with an expression
vector for GFP (2 mg) together with a control vector (Vector, 2 mg) or a plasmid for ANT-1 (ANT-1,
2 mg). After 16 h, the cells were treated with CMXRos, which stains mitochondria with an intact mem-
brane potential. Subsequently, phase-contrast and fluorescence microscopy pictures for GFP and
CMXRos activity were taken. (B) ANT-1 induces the release of cytochrome c from mitochondria.
293T cells were transfected with a control vector or an expression vector for ANT-1. Cytoplasmic ex-
tracts were prepared and assayed for the presence of cytochrome c (cyt c) by a Western blot. Molecu-
lar mass standards are given on the left. Equal loading of the gel is indicated by an upper unspecific
band with equal intensity. 
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C). These results show that ANT-1 leads to all phenotypic
and biochemical alterations associated with apoptosis.
 
The NH
 
2
 
-terminal Half of ANT-1 Is Sufficient for 
Apoptosis Induction
 
ANT-1 was originally described as an ADP/ATP exchange
factor (Riccio et al., 1975). To assess whether the transport
activity of ANT-1 is required for its apoptosis induction,
we generated six different point mutations, all of which
have been shown to impede ANT-1’s activity to transport
ADP and ATP (Muller et al., 1996; Muller et al., 1997).
However, upon transfection into 293T cells, we have not
observed any difference relative to the wild type (WT) in
their potential to induce apoptosis as measured by the re-
lease of internucleosomal DNA fragments (Fig. 5 A).
ANT-1 is a member of the mitochondrial carrier family
that consists of proteins with three 100-residue repeats
comprising alternating regions of hydrophilic and hydro-
phobic residues. As integral membrane proteins, they span
the membrane six times, interrupted by short amphipathic
helices that are likely to form the transport active moiety
(Klingenberg and Nelson, 1994). To map the domains re-
sponsible for apoptosis induction, we have created various
deletion mutants of ANT-1: ANT-1
 
D
 
 201 lacks the last two
transmembrane domains and the last amphipathic helix;
ANT-1
 
D
 
 142 cuts the molecule in half and comprises only
the first three transmembrane domains; and ANT-1
 
D
 
 102
contains only the first two membrane spanning domains.
Fig. 5 B demonstrates that ANT-1
 
D
 
 201 is as efficient for
apoptosis induction as WT ANT-1, whereas ANT-1
 
D
 
 142
revealed a 50% reduction of its apoptosis potential. The
largest deletion, ANT-1
 
D
 
 102, was inactive for apoptosis
induction.
Figure 4. Effect of ANT-1 on
protein and DNA degrada-
tion. (A) ANT-1 induces
internucleosomal DNA
cleavage. 293T cells were
transfected with an empty
vector or with an expression
construct for ANT-1. Low
molecular mass DNA was
isolated from transfected
cells, separated on a 2% aga-
rose gel, and stained with
ethidium bromide. (B) ANT-1
leads to the degradation of
PARP. 293T cells were trans-
fected with an empty control
vector, an expression vector for the death domain protein RIP or
with ANT-1. 16 h later, nuclear extracts of the transfected cells
were prepared and investigated for the status of PARP in a West-
ern blot. The generated PARP fragment is indicated by an arrow.
An unspecific signal (o) served as an internal control for equal
loading of the gel. (C) Inhibition of ANT-1 apoptosis by a spe-
cific inhibitor for caspases. ANT-1 (1 mg) and a control vector (10
mg) or an expression vector (10 mg) for the caspase inhibitor p35
from baculovirus were cotransfected, and the specific apoptosis
induction was determined by FACS analysis. The means and the
SDs are indicated (n 5 3).
Figure 5. Mutational analysis of ANT-1’s apoptosis activity. (A)
Cell death induction by point mutants of ANT-1. 1 mg of wild-
type ANT-1 (ANT-1 WT) and six point mutants that have been
shown to be deficient for ADP/ATP transport were transfected
into 293T cells. The wild-type amino acid, its position, as well as
the mutated residue are given for each mutant construct. After 16 h,
apoptosis induction by the various constructs was measured by
ELISA for internucleosomal DNA fragments. The DNA frag-
mentation as a percentage of control is given as an index for apop-
tosis induction. The means and the SDs are indicated (n 5 3). (B)
Apoptosis activity of ANT-1 deletion mutants. Wild-type ANT-1
(1 mg) or three COOH-terminal deletion mutants (1 mg) were
transiently transfected into 293T cells. The last COOH-terminal
residue of each deletion mutant is indicated. For the ANT-1 WT
and each mutant, the structure of the generated protein is de-
picted schematically with the membrane indicated as a shaded
area. After 16 h, the constructs were tested for apoptosis induc-
tion by a specific ELISA as described in A. 
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ANT-2 Is Unable to Induce Apoptosis
 
The PT pore complex is supposed to function by the con-
version of the specific ADP/ATP exchange transporter
into an unselective pore (Zoratti and Szabo, 1995). How-
ever, since over half of the ANT-1 protein is dispensable
for apoptosis induction, we wanted to know whether
ANT-1 induces apoptosis by forming an unspecific pore
on its own. Therefore, we assessed the specificity of apop-
tosis induction by ANT-1. To this end, we made use of
ANT-2, an over 90% identical gene to ANT-1 which is
likewise ubiquitously expressed (Doerner et al., 1997a).
Transfection of ANT-2 did not lead to apoptosis induction
as measured by fluorescence-activated cell sorter (FACS)
analysis (Fig. 6 A). The correct mitochondrial localization
and efficient expression of ANT-2 was verified by Western
blot (Fig. 6 B).
 
Growth of Yeast Cells Is Not Affected by ANT-1
 
Bax, a member of the Bcl-2 gene family, can induce a form
of cell death by overexpression in yeast cells (Greenhalf
et al., 1996; Zha et al., 1996; Jurgensmeier et al., 1997),
probably by activating ANT-1 and the PT pore (Greenhalf
et al., 1996; Marzo et al., 1998a). Therefore, we wanted to
determine whether ANT-1 has the same capacity. To ad-
dress this, we subcloned ANT-1 and Bax into a galactose-
and raffinose-inducible yeast vector. The induction of
these genes on suitable agar plates revealed that Bax led
to a reduction in the growth of these cells, indicating cell
death. In contrast, ANT-1–expressing yeast cells were
completely unaffected and grew as well as on the control
plate (Fig. 7 A). A Western blot revealed the efficient ex-
pression of Bax and ANT-1 in yeast cells upon induction
with galactose and raffinose. (Fig. 7 B)
 
Cyclophilin D Can Repress Apoptosis Induced
by ANT-1
 
Our experiments with ANT-2 and cell death in yeast sug-
gested that ANT-1’s apoptotic activity is mediated by spe-
cific protein–protein interactions rather than by forming
an active PT pore on its own. Nevertheless, to check
whether ANT-1 expression activates the endogenous PT
pore, we made use of bongkrekic acid, a specific inhibitor
Figure 6. Effect of ANT-1 and ANT-2 on transfected cells. (A)
Comparison between the apoptotic capacities of ANT-1 and
ANT-2. Expression plasmids for ANT-1 (1 mg) and ANT-2 (1 mg)
were transfected in 293T cells. After 16 h, apoptosis induction in
transfected cells was measured by FACS analysis of sub-G1–pos-
itive cells. The specific apoptosis induction above background is
shown as a percentage of apoptotic cells relative to all transfected
cells. The means and the SDs are indicated (n 5 3). (B) Expres-
sion and localization of ANT-1 and ANT-2. 293T cells were
transfected with a control vector or expression vectors for HA-
tagged ANT-1 and ANT-2. Mitochondrial extracts of transfected
cells were prepared and investigated for the presence of the pro-
teins with an anti–HA antibody in a Western blot. Equal loading
of the gel was verified by two unspecific upper bands.
Figure 7. Effect of Bax and ANT-1 expression on the growth of
yeast cells. (A) Bax but not ANT-1 leads to growth inhibition in
yeast. Bax and ANT-1 cloned in expression vectors under the
control of a galactose and raffinose-inducible promoter and the
empty control vector were introduced into yeast cells. 4.5 3 104
yeast cells of three independent clones each were plated on glu-
cose (glu)- or galactose and raffinose (gal/raf)–containing agar.
The growth of the yeast cells was monitored 36 h later. (B) Con-
trol of inducible expression of ANT-1 and Bax in yeast cells.
Yeast clones from A were kept in normal medium or incubated
in galactose and raffinose–containing medium for 8 h. Extracts
were prepared, and equal amounts (40 mg) of proteins were in-
vestigated for the expression of Bax and ANT-1 in a Western
blot. The antiserum against ANT-1 does also recognize the en-
dogenous yeast ANT-1. 
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for the PT pore (Klingenberg et al., 1970). 50 
 
m
 
M of this
compound repressed ANT-1–induced apoptosis in a quan-
titative apoptosis assay more than twofold (Fig. 8 A).
These findings together with the previous data from the
yeast experiments led us to speculate that ANT-1 might ti-
trate out some components of the endogenous PT pore
and that replenishing these proteins might repress apopto-
sis. Consequently, we cotransfected ANT-1 and an expres-
sion vector for cyclophilin D, a component of the PT pore
on the matrix side that directly interacts with ANT-1
(Woodfield et al., 1998). Quantification of apoptosis in-
duction revealed a more than twofold reduced cell death
by ANT-1 when cyclophilin D was cotransfected (Fig. 8 B).
 
Discussion
 
In this study, we have described the dominant activity of
ANT-1, a central component of the PT pore in mitochon-
dria, to induce apoptosis upon overexpression. This is the
first report that shows such an activity of a component of
the PT pore in the inner mitochondrial membrane. These
findings have important consequences for the normal state
of the cell: ANT-1 is already one of the most abundant
proteins in mitochondria and makes up 
 
z
 
10% of all pro-
teins in the inner mitochondrial membrane (Klingenberg,
1993). This means that its dominant activity for apoptosis
induction must be repressed by other proteins in a non-
apoptotic cell (see below).
In addition, ANT-1 is specifically and dramatically up-
regulated in heart tissue of patients with DCM (Schul-
theiss et al., 1996; Doerner et al., 1997b). DCM is a myo-
cardial disease of unknown etiology that is characterized
by a reduced myocardial contractility and ventricular dila-
tation. Its estimated prevalence is 36 in 100,000 and, there-
fore, represents a major cause of congestive heart failure
(Dec and Fuster, 1994). Interestingly enough, excessive
 
apoptosis can be observed in tissues from DCM patients
(Narula et al., 1996; Yao et al., 1996; Yamamura et al.,
1999). Even though different tissues with distinct ANT iso-
form levels might be differentially sensitive to ANT-1 ex-
pression, we would like to propose that this pathological
apoptosis induction is mediated by the increase in ANT-1.
Therefore, our studies might lead to an explanation and
possibly to a treatment of this disease.
Our initial hypothesis for the apoptosis induction by
ANT-1 was that it is was caused by its known function of
shuttling ATP and ADP over the mitochondrial mem-
brane. However, the apoptosis potential of ANT-1 seems
not to be dependent on its activity to transport ADP and
ATP, because a panel of point mutants that are inactive
for this transport could still induce apoptosis (Fig. 5).
While the transfected ANT-1 can, therefore, be impaired
for nucleotide exchange, the ADP/ATP transport activity
of the endogenous ANT-1 might still be relevant for apop-
tosis induction and be inhibited by the overexpressed
ANT-1.
The activation of the PT pore for apoptosis induction is
thought to be mediated by the PT pore becoming an un-
specific pore and releasing apoptogenic proteins and oxy-
gen radicals (Marzo et al., 1998b). Isolated ANT-1 has
been shown to form an unspecific, Ca
 
2
 
1
 
-dependent pore
(Brustovetsky and Klingenberg, 1996; Ruck et al., 1998).
Furthermore, ANT-1 can be activated for apoptosis in-
duction by atractyloside, a plant glucoside that binds to
ANT-1, stabilizes a specific conformation, and favors pore
opening (Zoratti et al., 1982; Davidson and Halestrap,
1987). Therefore, our second hypothesis was that overex-
pressed ANT-1 forms such an unspecific pore and thereby
reproduces an activated PT pore. However, several lines
of evidence suggest that overexpressed ANT-1 does not
form an unspecific pore. First, deletion studies with ANT-1
showed that the COOH-terminal half of the molecule, in-
cluding two transmembrane domains, is dispensable for
apoptosis induction (Fig. 5 B). It is hard to imagine how
such a truncated molecule could still form a membrane
channel. Second, ANT-2 was inactive for apoptosis induc-
tion (Fig. 6). Since this protein is over 90% identical to
ANT-1, it should also be capable of assembling into an un-
specific pore. Thirdly, if ANT-1 overexpression was suffi-
cient to form an unspecific channel, one would expect that
ANT-1 could induce cell death also in yeast. However, our
results show that ANT-1 was inactive in yeast (Fig. 7).
Therefore, we would like to propose a model (Fig. 9) in
which ANT-1, rather than forming an activated PT pore
by itself, stimulates the endogenous PT pore for apoptosis
induction. This is achieved by titrating out inhibitors of
this complex that activate the PT pore and induce apopto-
sis. One of these inhibitors could be cyclophilin D, which
we have shown to be able to repress ANT-1–induced apop-
tosis (Fig. 8 B). Alternatively, cyclophilin D might also
mask an interaction domain in ANT-1 for another protein
that is a repressor for the PT pore. Therefore, this protein
is not titrated out any more and the PT pore is not acti-
vated.
This interpretation of our results suggests that the stoi-
chiometry of the proteins in the PT pore complex is an im-
portant factor for its inactive state. The inner mitochon-
drial membrane would, therefore, mirror the condition in
Figure 8. Inhibition of ANT-1–induced apoptosis. (A) ANT-
1–induced apoptosis can be repressed by bongkrekic acid, a spe-
cific inhibitor of the PT pore. An expression vector for ANT-1 (1
mg) was transfected into plates with 293T cells. One group of
plates was left untreated, the other was supplied with 50 mM
bongkrekic acid (BA) for 16 h after the transfection. Apoptosis
was quantified as in Fig. 5. (B) ANT-1 apoptosis can be repressed
by cyclophilin D, another component of the permeability transi-
tion pore. ANT-1 (1 mg) and an expression plasmid (10 mg) for
cyclophilin D (Cyclo D) or a control vector (10 mg) were trans-
fected into 293T cells, and apoptosis was determined as described
in Fig. 6. 
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the outer membrane where the relative abundance of pro-
and anti-apoptotic proteins (e.g., the Bcl-2 family mem-
bers) determines apoptosis induction (Korsmeyer, 1995).
According to this model, ANT-1, instead of forming an
unspecific pore, would mediate apoptosis by specific pro-
tein–protein interactions. Different affinities for these pro-
teins could, therefore, account for ANT-2’s inactivity to
induce apoptosis.
Other proteins in our model would facilitate apoptosis
through ANT-1. Their existence is postulated because iso-
lated ANT proteins require the presence of Ca
 
2
 
1
 
 and,
therefore, cannot function as an unspecific pore on their
own (Brustovetsky and Klingenberg, 1996; Ruck et al.,
1998). These activators might not be titrated out by ANT-1
because their affinity to ANT-1 is dependent on the inter-
action with other proteins like, for example, Bax. Our data
from yeast might be explained by assuming that the inter-
action of ANT-1 with the inhibitors is not conserved be-
tween yeast and mammals, and that, therefore, these in-
hibitors are not titrated out. Alternatively, or in addition,
the inducer proteins in the mammalian complex are not
present in yeast or their interaction is regulated differ-
ently.
Based on previous studies with Bax (Oltvai et al., 1993)
and on this report about ANT-1, both proteins can induce
apoptosis upon overexpression. It was further shown that
they interact directly, and that the activation of ANT-1 for
apoptosis by the plant glucoside atractyloside required the
presence of Bax and vice versa (Marzo et al., 1998a). How-
ever, there are interesting differences in their capacity for
apoptosis induction: Bax can induce a form of cell death in
yeast, whereas ANT-1 is inactive (Fig. 7). As no Bcl-2–like
gene and, therefore, no Bax homologue is found in the
yeast genome, Bax might represent ANT-1’s missing inter-
action partner in yeast. The association between Bax and
ANT has been shown to be mediated by residues 105–156
of ANT (Marzo et al., 1998a). These sequences are also re-
quired for ANT-1 apoptosis induction (Fig. 5). This direct
Bax–ANT interaction might suggest that Bax is activated
by ANT-1 expression. However, Bax-induced apoptosis
does not seem to rely on caspase activation, even though
this protease family is activated when Bax is overex-
pressed (Xiang et al., 1996). ANT-1, on the other hand, re-
quires caspase activation as shown through the inhibition
by baculovirus p35 (Fig. 4 C). Furthermore, and most im-
portantly, even though ANT-2 has been shown to interact
with Bax (Marzo et al., 1998a), it is unable to induce apop-
tosis (Fig. 6). In addition, Bax might not be available for
interaction with the transfected ANT-1 in the cell because
the endogenous ANT-1 is already a very abundant protein
and might complex all endogenous Bax. For these reasons,
we believe that the transfected ANT-1 does not activate
the endogenous Bax, and that overexpressed ANT-1 in-
duces apoptosis in a different way than atractyloside-acti-
vated ANT. Taken together, ANT-1’s apoptosis induction
as described in this report shows how a protein that per-
forms the essential biological function to facilitate the
presence of ATP in the cytoplasm can also, under certain
conditions such as in DCM, turn into a protein that elicits
a deadly signal for the cell.
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